Home
News
Create
Screeners
Insights
Shree Ganesh Remedies
408.
00
-1.90
(-0.46%)
Market Cap
₹523.76 Cr
PE Ratio
25.78
Industry
Healthcare
Buy
Sell
Company Performance:
1D
-0.46%
1M
-6.35%
6M
-32.33%
1Y
-39.94%
5Y
+195.72%
View Company Insights
Latest news about Shree Ganesh Remedies
Shree Ganesh Remedies Reappoints Parth Kothia as Whole Time Director for Five Years
5 days ago
Shree Ganesh Remedies Limited's board approved the re-appointment of Mr. Parth Chandulal Kothia as Whole Time Director and CFO for five years from January 17, 2026. The Chemical Engineering graduate with an MS in Global Finance from Fordham University has over five years of experience in pharmaceutical business development and has been instrumental in driving company growth since 2021. His re-appointment, subject to shareholder approval, continues his dual role as director and CFO.
Shree Ganesh Remedies Strengthens Board with New Independent Director and Reappoints Cost Auditor
Aug 08, 2025
Shree Ganesh Remedies Faces Rs. 88.61 Lacs GST Summons Over Expired Stock
Jul 21, 2025
Shree Ganesh Remedies Reports Mixed Q4 Results with Profit Growth and Revenue Decline
May 19, 2025
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/Block Deals
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation